Guillain-Barré Syndrome (GBS) including Miller-Fisher syndrome and other variants

Recommended Indications in which IG can be used

Order Number: N4-GBS

Recommendations	IVIG is recommended for symptoms of grade 3 severity (able to walk with aid) or greater; or symptoms less than grade 3 severity that are progressing .   Treatment should be given within 2 weeks of symptom onset. Re-treatment for patients who do not respond may be considered.
Dose/Frequency of Administration	Adult: Total dose of 2 g/kg divided over 2 to 5 days.  Pediatric: Total dose of 2 g/kg divided over 2 days.  Repeat treatment with IVIG at 2 g/kg divided over 2 to 5 days .